Bronchial ethanol injection therapy for airway obstruction in lung cancer patients.

airway obstruction bronchial ethanol injection therapy low cost lung cancer

Journal

Respirology case reports
ISSN: 2051-3380
Titre abrégé: Respirol Case Rep
Pays: United States
ID NLM: 101631052

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 15 12 2020
accepted: 05 07 2021
entrez: 6 8 2021
pubmed: 7 8 2021
medline: 7 8 2021
Statut: epublish

Résumé

Obstructive endobronchial tumours often cause decreased quality of life. Bronchial ethanol injection (BEI) therapy is considered an effective modality for airway dilatation or haemoptysis without specialist equipment. Here, we report experiences of two cases in which BEI therapy was effective for obstructive endobronchial tumours. In Case 1 with adenoid cystic carcinoma of the lung, BEI therapy and balloon dilatation were performed as treatment for the left main bronchus restenosis after metallic stent insertion. In Case 2 with squamous cell carcinoma of the lung, BEI therapy was performed after radiation therapy to the lesion that recurred in the entrance of the superior segment of the right lower lobe. Tumour progression was controlled with multiple BEI therapy. We consider BEI therapy useful because this procedure is easy to conduct, has low cost and can be done under particular conditions including post-tracheobronchial stent placement and post-radiation.

Identifiants

pubmed: 34354837
doi: 10.1002/rcr2.816
pii: RCR2816
pmc: PMC8319722
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e0816

Informations de copyright

© 2021 The Authors. Respirology Case Reports published by John Wiley & Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology.

Déclaration de conflit d'intérêts

None declared.

Références

Gan To Kagaku Ryoho. 1999 Oct;26(12):1865-8
pubmed: 10560413
Respirology. 2012 Apr;17(3):478-85
pubmed: 22222022
Endoscopy. 1986 Sep;18(5):188-91
pubmed: 3780585

Auteurs

Fukuko Okabe (F)

Department of Thoracic Oncology Osaka Toneyama Medical Center Osaka Japan.

Yukihiro Yano (Y)

Department of Thoracic Oncology Osaka Toneyama Medical Center Osaka Japan.

Tomoki Kuge (T)

Department of Thoracic Oncology Osaka Toneyama Medical Center Osaka Japan.

Takeshi Uenami (T)

Department of Thoracic Oncology Osaka Toneyama Medical Center Osaka Japan.

Masaki Kanazu (M)

Department of Thoracic Oncology Osaka Toneyama Medical Center Osaka Japan.

Masahide Mori (M)

Department of Thoracic Oncology Osaka Toneyama Medical Center Osaka Japan.

Classifications MeSH